Related Experiment Video
Updated: Feb 25, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
[Primary membranous nephropathy presenting as relapsing ascites].
Kristine Lindhard1, Martin Egfjord, Otto Clemmesen
1kristine.lindhard@gmail.com.
A rare case of ascites in a patient without liver or heart disease was linked to primary membranous nephropathy. Immunotherapy targeting anti-PLA2R antibodies resolved the ascites, highlighting a novel connection.
Area of Science:
- Nephrology
- Immunology
Background:
- Ascites is a frequent complication of liver cirrhosis.
- Nephrotic syndrome can manifest with ascites, often alongside heart or liver disease and generalized edema.
- Primary membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
Observation:
- A 64-year-old male patient presented with recurrent ascites without other signs of edema or evidence of heart or liver disease.
- Diagnostic investigations revealed primary membranous nephropathy (MN).
- The patient tested positive for the autoantibody anti-PLA2R.
Findings:
- The patient's ascites resolved completely following immunotherapy.
- This case demonstrates a direct link between anti-PLA2R-associated primary MN and isolated ascites.
- Anti-PLA2R and anti-TSHD7A antibodies are implicated in diagnosing primary versus secondary MN.
Implications:
- Membranous nephropathy should be considered in the differential diagnosis of ascites, even in the absence of typical nephrotic syndrome features.
- Anti-PLA2R antibody testing is crucial for diagnosing and managing anti-PLA2R-associated MN.
- Targeting anti-PLA2R antibodies with immunotherapy offers a potential treatment strategy for ascites in MN patients.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Kidney Disease II: Clinical Manifestations
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
